Clinical Trials Logo

Hyperlipoproteinemia Type I clinical trials

View clinical trials related to Hyperlipoproteinemia Type I.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03198897 Withdrawn - Clinical trials for Lipoprotein Lipase Deficiency

Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

BioHoFH
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Homozygous familial Hypercholesterolemia from blood

NCT ID: NCT02904772 Withdrawn - LPL Deficiency Clinical Trials

Alipogene Tiparvovec for the Treatment of LPLD Patients

Start date: October 2016
Phase: Phase 2
Study type: Interventional

The aim of the study is to provide further confirmatory evidence of clinical benefit in LPLD patients treated with alipogene tiparvovec by assessing both the "clinical response" (as defined by a range of parameters), and "the metabolic response" (postprandial CM metabolism) in LPLD patients with and without an immunosuppressant regimen.